DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo


company name or ticker

This Stock Could Become the Next Johnson & Johnson

Our Motley Fool contributors think that these three companies could one day be as revered as J&J.

High Alpha In Shorting Infinity Pharmaceuticals With Potential Failure Of Upcoming Trials

Cancel JPMorgan! Plenty of Pre-Conference Data and Deals to Digest

The week before JPMorgan Healthcare conference brought a plethora of deals and data.

Infinity Pharmaceuticals Falls on Duvelisib Study Results - Analyst Blog

Morning Market Losers

Benzinga's Top #PreMarket Losers

Commit To Buy Infinity Pharmaceuticals At $10, Earn 10% Using Options

Weakness Seen in Infinity Pharmaceuticals (INFI): Stock Falls 12.4% - Tale of the Tape

Monday's ETF Movers: OIH, XBI

Infinity Pharmaceuticals (INFI) Is Today's Strong On High Volume Stock

See More Articles...